Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease

다국어 초록 (Multilingual Abstract)

Because nonalcoholic steatohepatitis can progress towards cirrhosis even in children, early detection of hepatic fibrosis and accurate diagnosis of nonalcoholic fatty liver disease (NAFLD) are important.
Although liver biopsy is regarded as the gold standard of diagnosis, its clinical application is somewhat limited in children due to its invasiveness. Noninvasive diagnostic methods, including imaging studies,biomarkers of inflammation, oxidative stress, hepatic apoptosis, hepatic fibrosis, and noninvasive hepatic fibrosis scores have recently been developed for diagnosing the spectrum of NAFLD,particularly the severity of hepatic fibrosis. Although data and validation are still lacking for these noninvasive modalities in the pediatric population, these methods may be applicable for pediatric NAFLD. Therefore, noninvasive imaging studies, biomarkers, and hepatic fibrosis scoring systems may be useful in the detection of hepatic steatosis and the prediction of hepatic fibrosis, even in children with NAFLD.

참고문헌 (Reference)

1 박소은, "비만을 동반한 소아 지방간 환아에서 체질량 지수, 체지방 분포, 간 효소치 및 복부 CT 소견과의 상관관계에 대한 연구" 대한소아과학회 48 (48): 276-283, 2005

2 양혜란, "비만아의 비알코올성 지방간 발병에 있어 Adipokine과 체지방분포 및 인슐린 저항성과의 연관성에 대한 연구" 대한소아소화기영양학회 10 (10): 185-192, 2007

3 Papandreou D, "Update on non-alcoholic fatty liver disease in children" 26 : 409-415, 2007

4 Shannon A, "Ultrasonographic quantitative estimation of hepatic steatosis in children with NAFLD" 53 : 190-195, 2011

5 Nobili V, "The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease" 7 : 21-, 2009

6 Powell EE, "The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years" 11 : 74-80, 1990

7 Feldstein AE, "The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years" 58 : 1538-1544, 2009

8 Pacifico L, "T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease" 17 : 3012-3019, 2011

9 Day CP, "Steatohepatitis: a tale of two 'hits'?" 114 : 842-845, 1998

10 Miele L, "Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease" 154 : 194-201, 2009

11 Fitzpatrick E, "Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD" 51 : 500-506, 2010

12 Lebensztejn DM, "Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease" 54 : 177-182, 2009

13 Charatcharoenwitthaya P, "Role of radiologic modalities in the management of non-alcoholic steatohepatitis" 11 : 37-54, 2007

14 양혜란, "Role of Tumor Necrosis Factor-a Promoter Polymorphism and Insulin Resistance in the Development of Non-alcoholic Fatty Liver Disease in Obese Children" 대한소아소화기영양학회 15 (15): 44-51, 2012

15 Nobili V, "Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease" 7 : 575-579, 2009

16 Piemonte F, "Protein glutathionylation increases in the liver of patients with non-alcoholic fatty liver disease" 23 (23): e457-e464, 2008

17 McGoogan KE, "Performance of the AST-to-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis" 50 : 344-346, 2010

18 Nobili V, "Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease" 136 : 160-167, 2009

19 Takahashi Y, "Pediatric nonalcoholic fatty liver disease: overview with emphasis on histology" 16 : 5280-5285, 2010

20 Roberts EA, "Pediatric nonalcoholic fatty liver disease (NAFLD): a 'growing' problem?" 46 : 1133-1142, 2007

21 Binkovitz LA, "Pediatric MR elastography of hepatic fibrosis: principles, technique and early clinical experience" 42 : 402-409, 2012

22 Nobili V, "Oxidative stress parameters in paediatric non-alcoholic fatty liver disease" 26 : 471-476, 2010

23 Sepulveda-Flores RN, "Obesity-related non-alcoholic steatohepatitis and TGF-beta1 serum levels in relation to morbid obesity" 1 : 36-39, 2002

24 Schwimmer JB, "Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease" 143 : 500-505, 2003

25 Molleston JP, "Obese children with steatohepatitis can develop cirrhosis in childhood" 97 : 2460-2462, 2002

26 Yang HR, "Noninvasive parameters and hepatic fibrosis scores in children with nonalcoholic fatty liver disease" 18 : 1525-1530, 2012

27 Wieckowska A, "Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future" 46 : 582-589, 2007

28 Yoneda M, "Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)" 40 : 371-378, 2008

29 Ludwig J, "Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease" 55 : 434-438, 1980

30 Carter-Kent C, "Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study" 50 : 1113-1120, 2009

31 Clark JM, "Nonalcoholic fatty liver disease" 122 : 1649-1657, 2002

32 Guha IN, "Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease" 55 : 1650-1660, 2006

33 Iacobellis A, "Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis" 12 : 7821-7825, 2006

34 Park SH, "Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment" 239 : 105-112, 2006

35 Shiha G, "Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)" 3 : 323-333, 2009

36 Wieckowska A, "In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease" 44 : 27-33, 2006

37 Georgoff P, "Hydrogen-1 MR spectroscopy for measurement and diagnosis of hepatic steatosis" 199 : 2-7, 2012

38 Nobili V, "Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease" 156 : 229-234, 2010

39 Schwimmer JB, "Histopathology of pediatric nonalcoholic fatty liver disease" 42 : 641-649, 2005

40 Bell LN, "Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes" 45 : 800-807, 2011

41 Chen J, "Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography" 259 : 749-756, 2011

42 Ratziu V, "Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease" 6 : 6-, 2006

43 Lesmana CR, "Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis" 10 : 201-206, 2009

44 Vajro P, "Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee" 54 : 700-713, 2012

45 Torres DM, "Diagnosis and therapy of nonalcoholic steatohepatitis" 134 : 1682-1698, 2008

46 Manning DS, "Diagnosis and quantitation of fibrosis" 134 : 1670-1681, 2008

47 Louthan MV, "Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease" 147 : 835-838, 2005

48 Yilmaz Y, "Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis" 15 : 4387-4391, 2009

49 Vos MB, "Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease" 47 : 481-485, 2008

50 Manco M, "Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease" 127 : 954-960, 2007

51 Shah AG, "Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease" 7 : 1104-1112, 2009

52 Friedrich-Rust M, "Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis" 10 : 103-, 2010

53 Patton HM, "Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis" 135 : 1961-1971, 2008

54 Ko JS, "Clinical and histological features of nonalcoholic fatty liver disease in children" 54 : 2225-2230, 2009

55 Bonnefont-Rousselot D, "Blood oxidative stress markers are unreliable markers of hepatic steatosis" 23 : 91-98, 2006

56 Loomba R, "Advances in pediatric nonalcoholic fatty liver disease" 50 : 1282-1293, 2009

57 Nobili V, "Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis" 48 : 442-448, 2008

58 Loaeza-del-Castillo A, "AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis" 7 : 350-357, 2008

59 Alkhouri N, "A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis" 9 : 150-155, 2011